Chapter 3: The Boardroom Coup
Chapter 3: The Boardroom Coup
The morning sun hit the glass facade of Ashford Tower like a golden blade, reflecting off the polished black marble of the main lobby where two dozen security guards stood in crisp, military-style uniforms. By 9:00 a.m., the atmosphere on the forty-second floor was charged with an electric, volatile tension.
The entire executive committee—twelve men and women who controlled the distribution of pharmaceuticals to over fifty countries—sat around the massive mahogany table. At the head of the table sat Arthur Vance, the senior legal counsel and Montgomery Ashford’s closest confidant for thirty years, his face a mask of cold, corporate discipline.
The double doors swung open, and Brennan walked into the room. He wasn't wearing his usual tailored overcoat; he was in a simple white shirt, his sleeves rolled up, a leather briefcase in his left hand. Behind him walked Marcus, looking pale but resolute, carrying a heavy stack of physical document folders.
"Brennan," Arthur Vance said, leaning forward, his tone dripping with an artificial, paternal concern. "We were worried about you. Your absence yesterday caused a massive panic among our European investors. There are already rumors of an internal leak regarding our patent renewals. We need you to sign these emergency stability declarations immediately so we can release them to the press."
Brennan didn't take his seat. He walked to the head of the table, dropped his briefcase onto the polished wood with a loud, echoing thud, and opened it.
"I won't be signing any declarations, Arthur," Brennan said, his voice calm, level, and entirely devoid of the deference he had shown these senior members for his entire career. "And as of ten minutes ago, the European patent renewals have been pulled from the regulatory registry."
The boardroom erupted into an immediate, chaotic uproar.
"Pulled?" the CFO gasped, standing up so fast his chair screeched against the floor. "Brennan, that renewal represents four hundred and fifty million dollars in projected revenue for the next quarter alone! You can't just pull a flagship patent without a full vote of the board!"
"I can when the patent was obtained through the active suppression of clinical trial data and the fraudulent concealment of a permanent medical cure," Brennan said, slamming a thick blue folder onto the center of the table.
Arthur Vance’s face instantly changed. The artificial warmth drained from his eyes, leaving behind the cold, calculating expression of an old predator who had just spotted an ambush. "Brennan, I think you should step into my office. You are speaking about sensitive internal R&D decisions that you clearly do not fully comprehend. Your father made those structural adjustments to protect the long-term viability of our research funds."
"My father killed a man, Arthur," Brennan said, leaning over the table, his eyes locking onto Vance’s with an intensity that made the older man flinch. "He ordered the recovery of David Miller’s research logs. He used our corporate compliance team to systematic blacklist his widow, Grace Miller, driving her and her six-year-old child onto the street so they wouldn't have the legal or financial resources to question the accident report from 2022. And you signed the nondisclosure authorizations for the security retainers that paid for it."
The room went dead silent. The other board members looked between Brennan and Vance, their faces turning various shades of pale as the realization of what was being disclosed began to sink in.
"This is absurd," Vance whispered, though his hand shook slightly as he adjusted his gold spectacles. "You have no proof of these wild accusations. If you bring this to the public, you will destroy this company. You will wipe out your own inheritance, Brennan. Everything your family built will be liquidated by the federal regulators."
"Then let it burn," Brennan said softly. "I’ve spent thirty-seven years living inside a palace built on the breath of sick children, Arthur. I am not spending another day protecting your inventory."
He turned to Marcus, who immediately opened his tablet and broadcasted a live stream to every screen in the boardroom. The display showed the main page of the federal patent office, where a new public filing had just been finalized under the title: The David Miller Memorial Open-Source Protocol for Pediatric Respiratory Care.
"Twenty minutes ago, I transferred the master chemical synthesis data for RespiCure’s permanent cure pathway to the World Health Organization under a non-commercial, open-source license," Brennan announced, his voice carrying like a bell in the quiet room. "Any laboratory in the world can now manufacture the permanent eradication compound for less than two dollars a dose. The proprietary market for RespiCure-DX no longer exists. We are no longer a pharmaceutical dynasty, gentlemen. We are a generic distribution logistics company. And our first order of business is to fund a permanent, fifty-million-dollar housing and medical trust for the victims of our historical pricing models."
Arthur Vance stood up, his face contorting in an unholy, desperate rage. "You’ve ruined us! You’re finished, Brennan! The board will vote to remove you as CEO before the markets open at 9:30! We will file an injunction for mental incompetence!"
May you like
"You can try," Brennan said, picking up his briefcase and walking toward the door. "But fifty-one percent of the voting stock still belongs to my personal trust. You don't have the numbers to remove me, Arthur. But the federal marshals who just entered the building have more than enough numbers to remove you. Have a good morning, everyone."
As Brennan walked out into the corridor, the elevator doors at the end of the hall opened, revealing four federal agents in dark jackets with gold lettering across the back. They didn't look at Brennan; they walked past him, straight into the boardroom, their voices booming through the doorway as they executed the corporate fraud warrants he had spent the night preparing with the U.S. Attorney’s office.
